OmniAb, Inc. Common Stock (OABI) Stock
NASDAQ · OABI
4.58
Fundamentals
Market cap
$649.90M
Price / Earnings ratio
-14.7x
Price / Sales ratio
16.9x
Price / Book ratio
2.5x
Return on assets
-0.2%
Ex-Dividend date
N/A
Last payment date
N/A
Dividend amount
$0.00
Dividend yield
0.0%
Debt / Equity ratio
N/A
Latest news
About OmniAb, Inc. Common Stock
OmniAb Inc licenses discovery research technology to pharmaceutical and biotech companies and academic institutions to enable the discovery of next-generation therapeutics. Its technology platform creates and screens diverse antibody repertoires and is designed to quickly identify optimal antibodies and other target-binding proteins for its partners' drug development efforts. At the heart of the OmniAb platform is what it calls Biological Intelligence, which powers the immune systems of proprietary, engineered transgenic animals to create optimized antibody candidates for human therapeutics.
SectorHealthcare
IndustryBiotechnology
Employees89
CEOMr. Matthew W. Foehr
IPO DateNov 2, 2022
HeadquartersEmeryVille, CA
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Matthew W. Foehr | President, CEO & Director | 1973 |
| Mr. Kurt A. Gustafson | Executive VP of Finance & CFO | 1968 |
| Mr. Charles S. Berkman J.D. | Chief Legal Officer | 1969 |
| Mr. Amechi Nwachuku | Executive VP & Chief Operating Officer | 1975 |
| Ms. Cia McCaffrey | Senior Vice President of People & Talent | — |
| Dr. Bill Harriman Ph.D. | Senior Vice President of Discovery Partnership Mgt., Technology Development & Operations | — |
| Dr. Christel Iffland Ph.D. | Senior Vice President of R&D Portfolio Management and Technology Operations | — |
| Dr. Yasmina Noubia Abdiche Ph.D. | Senior Vice President of Exploratory Research | — |
| Dr. Bob Chen | Senior Vice President of Discovery Systems | — |
| Mr. Todd Pettingill C.F.A. | Vice President of Business Development & Strategy | — |
Fundamentals
Valuation
Market cap$649.90M
Price-to-sales ratio16.90
Price-to-book value2.50
Price-earnings ratio-14.70
Return on Equity-20.00%
Return on SalesN/A
Return on AssetsN/A
PEG ratioN/A
Earnings Per Share
Earnings Per Share$-0.36
Income Statement
Average volume1,595,235
EBITDA$-31.03M
1 year high (52w)$5.43
1 year low (52w)$1.30
Dividend
Ex dividend dateN/A
Dividend amount$0.00
Dividend yield0.00%
Last payment dateN/A
Dividend yield (TTM)N/A
Next earnings reportN/A
Solvency
Debt-to-equity ratioN/A



